Trial intelligence / Profile preview

Levothyroxine soft-gel timing with breakfast in hypothyroidism replacement therapy

2016-001516-38Phase 4Terminated

Sponsor
PROF.EFISIO PUXEDDU, SEZIONE MEDICINA INTERNA SCIENZE ENDOCRINE E METABOLICHE, UNIVERSITÃ DI PERUGIA
Start
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of levothyroxine sodium in hypothyroidism (2 arms), sponsored by PROF.EFISIO PUXEDDU, SEZIONE MEDICINA INTERNA SCIENZE ENDOCRINE E METABOLICHE, UNIVERSITÃ DI PERUGIA. Started Jun 2021; status: terminated.

02

Drugs

levothyroxine sodium
03

Conditions

hypothyroidism

Beyond the preview

Go deeper on 2016-001516-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-001516-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call